Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

taVNS on Functional Mobility in People With DP

Study ID: NCT07366411
Start Date: 2026-02-15
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Active taVNS

Sham taVNS

Sponsor

Federal University of Pernambuco

Source: clinicaltrials.gov

Share:
Add to list

Sex-Specific Cerebrovascular Dysfunction in Metabolic Syndrome-Role of COX

Study ID: NCT07218653
Start Date: 2026-07
End Date: 2031-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

72

Intervention / Treatment

Indomethacin

Placebo

MRI

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Effects of Virtual Reality With Multisensory Stimulation on Emotional and Behavioral Disorders in Individuals With Acquired Brain Injury and Disability Requiring Institutional Care: a Single Case Experimental Design (SCED) Study.

Study ID: NCT07371260
Start Date: 2026-02-15
End Date: 2027-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

3

Intervention / Treatment

Virtual reality

Sponsor

La Musse Hospital

Source: clinicaltrials.gov

Share:
Add to list

Health Coaching for Patients With Cardiovascular Disease

Study ID: NCT06904144
Start Date: 2026-04-01
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Health Coaching

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

Study ID: NCT07285798
Start Date: 2026-02-27
End Date: 2029-08-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

176

Intervention / Treatment

KarXT

KarX-EC

KarXT + KarX-EC Matching Placebo

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome

Study ID: NCT07254299
Start Date: 2026-03-01
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

204

Intervention / Treatment

Hypnosis

Sponsor

COEN Matthew

Source: clinicaltrials.gov

Share:
Add to list

Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

Study ID: NCT07257198
Start Date: 2026-03-01
End Date: 2031-01-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

2570

Intervention / Treatment

Ticagrelor + placebo

Ticagrelor + aspirin

Sponsor

Montreal Heart Institute

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

Study ID: NCT05039892
Start Date: 2026-12
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

3D 185

Sponsor

3D Medicines (Beijing) Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial

Study ID: NCT07220187
Start Date: 2026-05-02
End Date: 2036-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

102

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Cyclophosphamide

Doxorubicin Hydrochloride

Echocardiography Test

Multigated Acquisition Scan

Pirtobrutinib

Positron Emission Tomography

Prednisone

Rituximab

Rituximab and Hyaluronidase Human

Survey Administration

Vincristine

Sponsor

SWOG Cancer Research Network

Source: clinicaltrials.gov

Share:
Add to list

Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals

Study ID: NCT07355556
Start Date: 2026-04-01
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

University of Nottingham

Source: clinicaltrials.gov

Share:
Add to list